Zoetis Inc. (NYSE:ZTS) Files An 8-K Regulation FD DisclosureItem 7.01. Regulation FD Disclosure.
On October 5, 2017, Zoetis Inc. (the Company) declared a dividend of $0.105 per share for the fourth quarter of 2017. The dividend will be paid on December 1, 2017 to all holders of record of the Company’s common stock as of the close of business on November 9, 2017.
The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
Item 7.01. Financial Statements and Exhibits.
|
(d) |
Exhibit: |
|
Press Release issued on October 5, 2017. |
Zoetis Inc. ExhibitEX-99.1 2 a2017q4dividendpressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1FOR IMMEDIATE RELEASE: Oct. 5,…To view the full exhibit click here
About Zoetis Inc. (NYSE:ZTS)
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.
